Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.170
+0.130 (6.37%)
Nov 21, 2024, 2:56 PM EST - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $64.35 million as of November 21, 2024. Its market cap has decreased by -63.35% in one year.
Market Cap
64.35M
Enterprise Value
14.08M
1-Year Change
-63.35%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $64.35M, a decrease of -82.41%. That is a compound annual growth rate of -40.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 60.49M | -71.88% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 61.85M |
| InterCure | 61.72M |
| VolitionRx | 61.71M |
| Exagen | 61.37M |
| Aileron Therapeutics | 61.10M |
| Agenus | 60.29M |
| Entera Bio | 60.04M |
| Boundless Bio | 59.98M |